|
|
||||||||
Articles |
1
DNA Diagnostics Business Unit, and
2
IRCCS Clinical Molecular Biology Laboratory, H. San Raffaele, via Olgettina 60, 20132 Milan, Italy.
3
Clinical Diagnostics Group, Bio-Rad
Laboratories, 2000 Alfred Nobel Dr., Hercules, CA 94547.
a Author for correspondence. Fax 510-741-5811; e-mail bwallace{at}bio-rad.com
We can detect the ß-globin gene sickle cell mutation by using an assay based on the ligase chain reaction. The simultaneous amplification of the human growth hormone gene in the same reaction serves as a control for the amount of template DNA or amplification efficiency. Ligation products, which are biotinylated at one end and tagged with an arbitrary "tail" sequence at the other, are captured by hybridization to "tail"-complementary oligonucleotides immobilized on polystyrene microwells. The captured ligation products are detected colorimetrically by use of streptavidinalkaline phosphatase conjugate. In a study of 24 subjects, the assay unequivocally discriminated among normal, carrier, and sickle cell genotypes.
Key Words: indexing terms: hemoglobinopathies DNA amplification genetic diseases human growth hormone gene biotinstreptavidin interaction
The following articles in journals at HighWire Press have cited this article:
![]() |
A. K. Tong and J. Ju Single nucleotide polymorphism detection by combinatorial fluorescence energy transfer tags and biotinylated dideoxynucleotides Nucleic Acids Res., March 1, 2002; 30(5): e19 - e19. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |